男女羞羞视频在线观看,国产精品黄色免费,麻豆91在线视频,美女被羞羞免费软件下载,国产的一级片,亚洲熟色妇,天天操夜夜摸,一区二区三区在线电影

News >Bizchina

New R&D center tackles diabetes

2010-11-04 14:33

New R&D center tackles diabetes

A researcher at an Eli Lilly laboratory in Suzhou, Jiangsu province. The US company hopes to expand its research capabilities in Shanghai with the opening of its new diabetes research and development center. [Photo/China Daily]

BEIJING - US-based pharmaceutical company Eli Lilly and Company announced on Tuesday the establishment of a diabetes research center in Shanghai and the hiring of 100 scientific and support staff, most of whom will be domestic hires.

The center will officially open in the second half of 2011, said Jan Lundberg, executive vice-president of Science and Technology of Lilly and president of Lilly Research Laboratories.

It aims to meet China's growing demand for innovative diabetes medicine that suits local patients.

"This center will complement our existing network of collaborations in China and also will enable us to further gain the insights of China's talented scientists," he said.

The company already has an R&D facility in Zhangjiang Hi-tech Park, Shanghai.

In 2003, Lilly started cooperating with Shanghai ChemExplorer Co Ltd, a local medical R&D outsourcing company.

The two sides also set up PharmaExplorer and BioExplorer, providing exclusive services for Lilly.

According to a recent article in The New England Journal of Medicine, about 92 million Chinese people (around 10 percent of the nation's adult population), have diabetes and the number of patients is expected to increase in the next decade.

"Lilly's presence in China spans every aspect of our business, from R&D to manufacturing to sales to marketing," said Jacques Tapiero, senior vice-president of Lilly and president of Lilly's Emerging Market Business Area.

He added that the drugmaker will focus not only on first-tier cities but also on second and third-tier cities where the number of diabetes patients is also increasing fast.

Lilly entered China in 1993 with operations and research facilities in Shanghai. According to Eric Baclet, president of Lilly China, Lilly's payroll in China doubled during the past two years to 3,000.

It also established a venture capital fund in 2007 called Lilly Asian Ventures to invest in China's biopharmaceutical industry.

According to Tapiero, given the growing demand for diabetes medicine in China, Lilly plans to surpass the 24-25 percent average annual growth of the nation's pharmaceutical market.

Related News:

主站蜘蛛池模板: 古交市| 漳州市| 长武县| 兴国县| 登封市| 郑州市| 神农架林区| 渑池县| 阿城市| 波密县| 井冈山市| 康乐县| 临沭县| 临澧县| 祁门县| 平罗县| 喀喇沁旗| 景洪市| 湖北省| 彭阳县| 新密市| 利津县| 白玉县| 安新县| 临澧县| 奉贤区| 盘锦市| 乌海市| 什邡市| 南和县| 大冶市| 临泽县| 彰武县| 桐城市| 普宁市| 灯塔市| 洪泽县| 浙江省| 屏南县| 杨浦区| 建昌县| 龙里县| 辽阳市| 芒康县| 枣庄市| 岳普湖县| 洛宁县| 崇文区| 芦山县| 宜章县| 宜兰县| 扎兰屯市| 临汾市| 浦江县| 怀来县| 东方市| 巨野县| 明水县| 新竹县| 改则县| 阿拉善盟| 溧阳市| 四川省| 鹤岗市| 丹阳市| 舞阳县| 始兴县| 苍梧县| 延庆县| 石屏县| 景泰县| 通道| 信阳市| 长岭县| 大理市| 金堂县| 大庆市| 星座| 逊克县| 嘉禾县| 保山市| 水富县|